Xi Yang, Chenglong Li, Hong Zheng, Xiaobing Huang. "The venetoclax combined with metronomic low-dose decitabine and interferon for preventing post-transplant relapse in high-risk MDS and AML patients." Blood (2025). https://doi.org/10.1182/blood-2025-7793